Axcelis Announces Participation In Seventh Annual NYC Investor Summit 2018
Summary
BEVERLY, Mass., Nov. 28, 2018 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today that Kevin Brewer, executive vice president and CFO, will attend the 7th Annual NYC Investor Summit 2018, being held December 11, 2018 at the Parker New York Hotel, New York City. The presentation material used during the event will be made accessible on the investor page of Axcelis website at www.axcelis.com. The 17 management teams collectively hosting the 2018 NYC Summit include: ACM Research (ACMR), Advanced Energy Industries (AEIS), Aehr Test (AEHR), Alpha & Omega Semiconductor (AOSL), Axcelis (ACLS), BE Semiconductor Industries (BESI.AS), Brooks (BRKS), Cohu (COHU), FormFactor (FORM), Ichor Systems (ICHR), Intermolecular (IMI), inTEST Corporation (INTT), Intevac (IVAC), Kulicke & Soffa (KLIC), Nanometrics (NANO), Rudolph Technologies (RTEC), and Veeco Instruments (VECO). The NYC Summit is by invitation only and is open to accredited investors and publishing research analysts. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process.